These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 19797012

  • 21. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E, Dini L.
    Mol Pharm; 2014 Aug 04; 11(8):2527-38. PubMed ID: 24921216
    [Abstract] [Full Text] [Related]

  • 22. Polyether ionophores-promising bioactive molecules for cancer therapy.
    Huczyński A.
    Bioorg Med Chem Lett; 2012 Dec 01; 22(23):7002-10. PubMed ID: 23063400
    [Abstract] [Full Text] [Related]

  • 23. Revisiting the ABCs of multidrug resistance in cancer chemotherapy.
    Tiwari AK, Sodani K, Dai CL, Ashby CR, Chen ZS.
    Curr Pharm Biotechnol; 2011 Apr 01; 12(4):570-94. PubMed ID: 21118094
    [Abstract] [Full Text] [Related]

  • 24. Autophagy inhibition in combination cancer treatment.
    Livesey KM, Tang D, Zeh HJ, Lotze MT.
    Curr Opin Investig Drugs; 2009 Dec 01; 10(12):1269-79. PubMed ID: 19943199
    [Abstract] [Full Text] [Related]

  • 25. Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1.
    Chang XB.
    Methods Mol Biol; 2010 Dec 01; 596():223-49. PubMed ID: 19949927
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. SLC22 transporter family proteins as targets for cytostatic uptake into tumor cells.
    Gupta S, Burckhardt G, Hagos Y.
    Biol Chem; 2011 Jan 01; 392(1-2):117-24. PubMed ID: 21194368
    [Abstract] [Full Text] [Related]

  • 28. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
    Wu Q, Yang Z, Nie Y, Shi Y, Fan D.
    Cancer Lett; 2014 Jun 01; 347(2):159-66. PubMed ID: 24657660
    [Abstract] [Full Text] [Related]

  • 29. Molecular markers of multiple drug resistance in breast cancer.
    O'Driscoll L, Clynes M.
    Chemotherapy; 2006 Jun 01; 52(3):125-9. PubMed ID: 16612055
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mechanisms and strategies to overcome multiple drug resistance in cancer.
    Ozben T.
    FEBS Lett; 2006 May 22; 580(12):2903-9. PubMed ID: 16497299
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy.
    Liu S, Khan AR, Yang X, Dong B, Ji J, Zhai G.
    J Control Release; 2021 Jul 10; 335():1-20. PubMed ID: 33991600
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.
    Dinic J, Podolski-Renic A, Stankovic T, Bankovic J, Pesic M.
    Curr Pharm Des; 2015 Jul 10; 21(38):5589-604. PubMed ID: 26429711
    [Abstract] [Full Text] [Related]

  • 38. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development.
    Moitra K, Lou H, Dean M.
    Clin Pharmacol Ther; 2011 Apr 10; 89(4):491-502. PubMed ID: 21368752
    [Abstract] [Full Text] [Related]

  • 39. [Host defense peptides and peptidomimetics as new weapons for cancer treatment].
    Lapis K.
    Magy Onkol; 2010 Mar 10; 54(1):47-58. PubMed ID: 20350868
    [Abstract] [Full Text] [Related]

  • 40. Death by design: where curcumin sensitizes drug-resistant tumours.
    Saha S, Adhikary A, Bhattacharyya P, DAS T, Sa G.
    Anticancer Res; 2012 Jul 10; 32(7):2567-84. PubMed ID: 22753715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.